Registry of the patients with rheumatoid arthritis treated with Biologics in routine clinical practice.

Registry of the patients with rheumatoid arthritis treated with Biologics in routine clinical practice. - FRAB Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007224

Enrollment

2000

Registered

2012-02-03

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Fulfill the 1987 ACR or 2010 ACR/EULAR classification criteria for RA. 2)RA patients who treated in biologics ( Tocilizumab, Infliximab, Etanercept, Adalimumab, Abatacept, and Golimumab) at clinical practice. 3)Patients who obtains agreement for participation in present this study.

Exclusion criteria

Exclusion criteria: When a patient is regarded as inappropriate to join the study by physicians' discretion When a patient withdraw consent to this study

Design outcomes

Primary

Measure	Time frame
Clinical remission rate	—

Secondary

Measure	Time frame
Continuation rate, time course of DAS-ESR, incidence rate and type of adverse events.	—

Countries

Japan

Contacts

Public ContactYasuharu Nakashima

Kyushu University Department of Orthopaedic Surgery

yasunaka@ortho.med.kyushu-u.ac.jp092-642-5487

Outcome results